Doxorubicin HCl; DOX
25316-40-9
579.98
C27H29NO11 • HCl
DMSO, Ethanol
2-8°C
Doxorubicin hydrochloride is the most extensively studied of a family of highly fluorescent anthracycline antibiotics produced by several Streptomyces species, first reported in 1967 and later approved for human therapeutic use as an antitumor agent for the treatment of a wide range of cancers. Doxorubicin also exhibits anti-HIV and antibacterial activity. The mode of action of doxorubicin is thought to be due to intercalation of DNA and inhibition of nucleic acid synthesis.
0.1 lbs
Research or further manufacturing use only, not for food or drug use.
